Clinical Trial Update: A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update comparing inhaled ciclesonide with placebo in children aged 6 to 11 with asthma. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ciclesonide (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2016-08-16